Life ScienceCompany
Who owns BioSpecifics Technologies?
BioSpecifics Technologies is owned by Endo International. It was acquired in 2020.
BioSpecifics Technologies is owned by Endo International. It was acquired in 2020.
Delaware Corporate Center II, 2 Righter Parkway, Suite 200,
Wilmington, Delaware
19803
United States,
(302) 842-8450
www.biospecifics.com
| Status | Dates | Investor(s) | |
|---|---|---|---|
| Investment | Exit | ||
| Current | 2020-10-19 | Endo International | |
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.